A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Gingival Recession

Interventions

BIOLOGICAL

Acellular Dermal Matrix

ADM is a human-derived allograft material, treated to remove all cellular components so that only the connective tissue matrix remains.

Trial Locations (1)

Tufts University School of Dental Medicine, Boston

All Listed Sponsors

lead

Tufts University

OTHER